1 unknown. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Unknown 1 |
Follow Breast Carcinoma: new trials by email Literature Review of Breast Carcinoma trials Research Report on Breast Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults Olaparib, Lenvatinib, Sunitinib - Renal Cell Carcinoma, Ovarian Carcinoma | Phase 4 | Unknown | University Medical Center Groningen | 30 | 2024-05-01 | 2023-11-29 |
Breast Neoplasms (1) · Carcinoma, Renal Cell (1) · Endometrial Neoplasms (1) · Ovarian Neoplasms (1) · Thyroid Neoplasms (1)
Adenocarcinoma (1) · Adnexal Diseases (1) · Breast Diseases (1) · Carcinoma (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Gonadal Disorders (1) · Head and Neck Neoplasms (1) · Kidney Diseases (1) · Kidney Neoplasms (1)
Sunitinib (1) · lenvatinib (1) · olaparib (1) · palbociclib (1) · pazopanib (1)
University Medical Center Groningen (1)
Netherlands (1)